Impact of corticosteroids and immunosuppressive therapies on symptomatic SARS-CoV-2 infection in a large cohort of patients with chronic inflammatory arthritis

Impact of corticosteroids and immunosuppressive therapies on symptomatic SARS-CoV-2 infection in a large cohort of patients with chronic inflammatory arthritis

Abstract Background Prevalence and outcomes of coronavirus disease (COVID)-19 in relation to immunomodulatory medications are still unknown. The aim of the study is to investigate the impact of glucocorticoids and immunosuppressive agents on COVID-19 in a large cohort of patients with chronic immune...

Full description

Bibliographic Details
Main Authors: Ennio Giulio Favalli, Serena Bugatti, Catherine Klersy, Martina Biggioggero, Silvia Rossi, Orazio De Lucia, Francesca Bobbio-Pallavicini, Antonella Murgo, Silvia Balduzzi, Roberto Caporali, Carlomaurizio Montecucco
Format: Article
Language:English
Published: BMC 2020-12-01
Series:Arthritis Research & Therapy
Subjects:
COVID-19
SARS-CoV-2
Rheumatic diseases
Biologic drugs
Glucocorticoids
Online Access:https://doi.org/10.1186/s13075-020-02395-6

Internet

https://doi.org/10.1186/s13075-020-02395-6

Similar Items